Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA

April 5, 2024

First T-cell treatment for a solid tumor Amtagvi approved by the FDA from Iovance

February 23, 2024

Life Sciences Voice Top Five Newsletter

July 20, 2025

Must Read

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

July 1, 2026

Top 10 Real-World Use Cases for AI in Clinical Development

July 1, 2026

Why Medical Affairs Teams Need New Skills for the Next Decade

July 1, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

AbbVie and Genmab Report Positive Phase 3 Results for Epkinly Combination in Diffuse Large B-Cell Lymphoma

Vistagen Misses Second Phase 3 Social Anxiety Trial but Sees Potential Path Forward

Zymeworks to Acquire Theravance in $929 Million Deal

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

Biogen Pens $1B Deal to Acquire RayThera, Bagging Preclinical Immunology Assets

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Top 10 Real-World Use Cases for AI in Clinical Development

Why Medical Affairs Teams Need New Skills for the Next Decade

Top 10 Trends Reshaping Biotech R&D Infrastructure

The Rise of Multi-Omics in Drug Development

Commercial

Chiesi and Arbor Biotechnologies Enter $2 Billion Gene Therapy Partnership for Rare Liver Disease

Editor Picks

Eisai and Biogen’s injectable Alzehimer drug faces setback from the FDA

First T-cell treatment for a solid tumor Amtagvi approved by the FDA from Iovance

Life Sciences Voice Top Five Newsletter

Must Read

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

Top 10 Real-World Use Cases for AI in Clinical Development

Why Medical Affairs Teams Need New Skills for the Next Decade

Hot Topics

About Us

Follow Us